Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Revolution Medicines, Inc. (RVMD) has a Wall Street consensus price target of $122.25, based on estimates from 20 covering analysts. With the stock currently trading at $102.02, this represents a potential upside of +19.8%. The company has a market capitalization of $20.10B.
Analyst price targets range from a low of $73.00 to a high of $170.00, representing a 79% spread in expectations. The median target of $141.50 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 19 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, RVMD trades at a trailing P/E of -17.1x. Analysts expect EPS to grow -27.2% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how RVMD stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonRevolution Medicines, Inc. (RVMD) has a consensus 12-month price target of $122.25, implying 19.8% upside from $102.02. The 20 analysts covering RVMD see moderate appreciation potential.
RVMD has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 19 Buy/Strong Buy ratings. The consensus 12-month price target of $122.25 implies 19.8% upside from current levels.
RVMD's current price is $102.02 with a consensus target of $122.25 (19.8% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $170 for RVMD, while the most conservative target is $73. The consensus of $122.25 represents the median expectation. These targets typically reflect 12-month expectations.
RVMD is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 18 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month RVMD stock forecast based on 20 Wall Street analysts shows a consensus price target of $122.25, with estimates ranging from $73 (bear case) to $170 (bull case). The median consensus rating is "Buy".
Wall Street analysts are optimistic on RVMD, with a "Buy" consensus rating and $122.25 price target (19.8% upside). 19 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
RVMD analyst price targets range from $73 to $170, a 79% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $122.25 consensus represents the middle ground.